Source: Business Standard

Pierre Fabre: Jubilant Biosys expands global footprint with acquisition in France

This acquisition marks a significant step in Jubilant Biosys' global strategy, providing a foothold in Europe's expanding pharmaceutical and biotech ecosystem

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
10-50K
Eric Ducournau's photo - CEO of Pierre Fabre

CEO

Eric Ducournau

CEO Approval Rating

77/100

Read more